Matthew J. O’Shaughnessy

Author

Also Known As

Blazar, B. R., M.J. O’Shaughnessy, Matthew J O’Shaughnessy, Matthew J. O'Shaughnessy, Matthew J. O’Shaughnessy, Matthew O'Shaughnessy, Matthew O'shaughnessy, Vogtenhuber, C.

Publications

899

Citations

H-Index

Concepts

All Affiliations

University of Minnesota University of Minnesota Medical Center Masonic Cancer Center Stanford University University Hospital of Basel

About

Matthew J. O’Shaughnessy is an author at University of Minnesota specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	431
2	Cell Biology	2	2	258
3	Engineering	1	1	89
4	Biology	1	1	89
5	Cellular Therapies	1	1	241

Matthew J. O’Shaughnessy

Publications

813

Citations

H-Index

Page 1

	Year	Citations
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib Kai Sun, Angela Panoskaltsis‐Mortari, Matthew J. O’Shaughnessy, Proceedings of the National Academy of Sciences Cell TherapyGvhd-associated ParametersImmunologyProteasome Inhibitor BortezomibPathology	2004	241
Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells Marta Serafini, Scott J. Dylla, Masayuki Oki, The Journal of Experimental Medicine	2007	114
Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors Matthew J. O’Shaughnessy, Katie S. Murray, Stephen P. La Rosa, Clinical Cancer Research	2017	95
Differentiation of Ingested and Endogenous Bifidobacteria by DNA Fingerprinting Demonstrates the Survival of an Unmodified Strain in the Gastrointestinal Tract of Humans , , , Martin J. Kullen, Mary M. Amann, Matthew J. O’Shaughnessy, Journal of Nutrition BiologyEngineeringUnmodified StrainDna FingerprintingEnvironmental Microbiology	1997	89
Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells Jakub Tolar, Matthew J. O’Shaughnessy, Angela Panoskaltsis‐Mortari, Blood	2006	79
A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer Matthew J. O’Shaughnessy, Sean M. McBride, Hebert Alberto Vargas, Urology UrologyAccelerate Drug EvaluationsPreclinical Drug EvaluationMedicinePharmacology	2016	70
Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming Steven L. Highfill, Ryan Kelly, Matthew J. O’Shaughnessy, Blood	2009	61
Elevation of Intracellular Cyclic AMP in Alloreactive CD4+ T Cells Induces Alloantigen-Specific Tolerance That Can Prevent GVHD Lethality In Vivo Matthew J. O’Shaughnessy, Zong-Ming Chen, Irene Gramaglia, Biology of Blood and Marrow Transplantation	2007	18
Ex vivo Inhibition of NF-κB Signaling in Alloreactive T-cells Prevents Graft-Versus-Host Disease Matthew J. O’Shaughnessy, Christine Vogtenhuber, Kai Sun, American Journal of Transplantation InflammationTransplantationAutoimmune DiseaseEx Vivo InhibitionImmunology	2009	17
Outgrowth of CD4low/negCD25+ T Cells with Suppressor Function in CD4+CD25+ T Cell Cultures upon Polyclonal Stimulation Ex Vivo Christine Vogtenhuber, Matthew J. O’Shaughnessy, Dario A.A. Vignali, The Journal of Immunology	2008	15

Page 1